Literature DB >> 19878775

Chapter 7: Cell protective functions of secretory Clusterin (sCLU).

Gerd Klock1, Markus Baiersdörfer, Claudia Koch-Brandt.   

Abstract

Secretory clusterin (sCLU) is found as an 80-kDa glycoprotein in virtually all body fluids, in serum it is associated with high-density lipoprotein (HDL). Here, we discuss demonstrated and proposed mechanisms of the cytoprotective functions of sCLU in instances of apoptosis, necrosis, and disease. These include prevention from cell damage by lipid oxidation in blood vessels, removal of dead cell remnants in tissues undergoing various forms of cell death, and clearance of harmful extracellular molecules such as amyloid beta (Abeta) by endocytosis or transcytosis. All these functions may reflect the propensity of sCLU to bind to a wide spectrum of hydrophobic molecules on one hand and to specific cell-surface receptors on the other hand. Identified and proposed sCLU receptors are members of the LDL receptor family of endocytosis receptors. Since these receptors recently have proved to modulate cell signaling we will discuss whether sCLU due to this interaction not only targets its ligands for clearance, but may also be involved in triggering signal transduction.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19878775     DOI: 10.1016/S0065-230X(09)04007-X

Source DB:  PubMed          Journal:  Adv Cancer Res        ISSN: 0065-230X            Impact factor:   6.242


  9 in total

1.  Increased extracellular clusterin in the prefrontal cortex in schizophrenia.

Authors:  Katina M Athanas; Sarah L Mauney; Tsung-Ung W Woo
Journal:  Schizophr Res       Date:  2015-10-21       Impact factor: 4.939

2.  Time-dependent decrease of clusterin as a potential cerebrospinal fluid biomarker for drug-resistant epilepsy.

Authors:  Weihua Yu; Dan Chen; Zhihua Wang; Chunlei Zhou; Jing Luo; Yali Xu; Lan Shen; Huan Yin; Shuxin Tao; Zheng Xiao; Fei Xiao; Yang Lü; Xuefeng Wang
Journal:  J Mol Neurosci       Date:  2014-02-02       Impact factor: 3.444

3.  Serum amyloid a protein in clinical cancer diagnosis.

Authors:  Chibo Liu
Journal:  Pathol Oncol Res       Date:  2011-09-08       Impact factor: 3.201

4.  Clusterin signals via ApoER2/VLDLR and induces meiosis of male germ cells.

Authors:  Muhammad Assad Riaz; Angelika Stammler; Mareike Borgers; Lutz Konrad
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

5.  Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson's disease subjects.

Authors:  Chera L Maarouf; Thomas G Beach; Charles H Adler; Holly A Shill; Marwan N Sabbagh; Terence Wu; Douglas G Walker; Tyler A Kokjohn; Alex E Roher
Journal:  Neurol Res       Date:  2012-09       Impact factor: 2.448

6.  Clusterin is a ligand for apolipoprotein E receptor 2 (ApoER2) and very low density lipoprotein receptor (VLDLR) and signals via the Reelin-signaling pathway.

Authors:  Christian Leeb; Christine Eresheim; Johannes Nimpf
Journal:  J Biol Chem       Date:  2013-12-31       Impact factor: 5.157

7.  pVHL mediates K63-linked ubiquitination of nCLU.

Authors:  Jing Xue; Dan-Dan Lv; Shi Jiao; Wenting Zhao; Xuebing Li; Heng Sun; Bing Yan; Li Fan; Rong-Gui Hu; Jing Fang
Journal:  PLoS One       Date:  2012-04-20       Impact factor: 3.240

8.  Proteomic analysis of sera from common variable immunodeficiency patients undergoing replacement intravenous immunoglobulin therapy.

Authors:  Giuseppe Spadaro; Concetta D'Orio; Arturo Genovese; Antonella Galeotafiore; Chiara D'Ambrosio; Stefano Di Giovanni; Monica Vitale; Mario Capasso; Vincenzo Lamberti; Andrea Scaloni; Gianni Marone; Nicola Zambrano
Journal:  J Biomed Biotechnol       Date:  2011-09-22

9.  Clusterin role in hepatocellular carcinoma patients treated with oxaliplatin.

Authors:  Xiumei Wang; Yongqiang Liu; Qiong Qin; Ti Zheng
Journal:  Biosci Rep       Date:  2020-02-28       Impact factor: 3.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.